Trial intelligence / Profile preview

Ketamine adjunct to bupivacaine for cleft lip surgery analgesia

NCT02514980Phase 3Completed

Sponsor
Assiut University
Start
Aug 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketamine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Postoperative analgesic consumption at 24 hours. Started Aug 2015; status: completed.

02

Drugs

ketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02514980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02514980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call